Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor (Ensitrelvir)
Clinical trial NCT05605093 · TERMINATED
Trial details
- NCT number
- NCT05605093
- Sponsor
- University of Minnesota
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-23
- Primary completion
- 2025-10-28
- Enrollment
- 602
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.